Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population.

Javier Garde-NogueraM Leonor Fernández-MurgaVicent Giner-BoschVictoria Dominguez-MárquezJosé García SánchezJuan José Soler-CataluñaFranscica López ChuliáBeatriz HonrubiaNuria PieraAntonio Llombart-Cussac

Published in: Cancers (2020)

Patients with cancer present higher risks for hospital needs for COVID-19 infection. The lack of SARS-CoV-2 seroconversion may be a concern for patients on immunosuppressive therapies. Patients receiving systematic therapies relayed a high rate of potentially COVID-19-related symptoms, particularly those receiving chemotherapy. However, the seroconversion rate remains low and in the range of general population.

Keyphrases

sars cov
respiratory syndrome coronavirus
end stage renal disease
coronavirus disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
healthcare
emergency department
locally advanced
physical activity
sleep quality
climate change
depressive symptoms
radiation therapy